[en] Objective: To determine whether assessment of plasma fibronectin in primigravidae could predict the pregnant women expected to become preeclamptic. Methods: We performed a prospective blinded analysis of 156 apparently normotensive primigravidae in an outpatient clinic. Blood samples were taken at 6 week intervals from the 18th week and immediately after delivery or at the onset of preeclampsia. Plasma fibronectin was evaluated by ELISA. Evolution with gestational age was studied using regression curves. Results: We had 148 normal primigravidae (592 determinations). In three women, increased fibronectin anticipated preeclampsia by 3–4 weeks. Five women showed high levels only at the onset of preeclampsia. Sensitivity, specificity, positive and negative predictive values of increased fibronectin levels were 37.5% (95% CI53.3–71.7), 96.6% (95% CI593.7–99.6), 37.5% (95% CI53.3–71.7) and 96.6% (95% CI593.7–99.6), respectively. Conclusions: This study shows that plasma fibronectin levels could represent a specific marker for preeclampsia. Its sensitivity has to be improved but its high negative predictive value strongly argues against the development of preeclampsia within the next 4 weeks after the blood sampling.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Dreyfus, M.
Baldauf, J. J.
Ritter, J.
VAN CAUWENBERGE, Jean-Rémy ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Sénologie -Obstétrique CHBA
Hardy, André ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie-Obstétrique-Sénologie
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Language :
English
Title :
The prediction of preeclampsia: Reassessment of clinical value of increased plasma levels of fibronectin
Publication date :
1998
Journal title :
European Journal of Obstetrics and Gynecology and Reproductive Biology
Friedman S.A., de Groot C.J.M., Taylor R.N., Golditch B.D., Roberts J.M. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol. 170:1994;838-841.
Vartio T., Laitinen L., Närvänen O.et al. Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci. 88:1987;419-430.
Stubbs T.M., Lazarchick J., Horger III E.O. Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol. 150:1984;885-887.
Eriksen H.O., Kern Hansen P., Brocks V., Jensen B.A. Plasma fibronectin concentration in normal pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand. 66:1987;25-28.
Micheli M., De Franco A., Nitti M.et al. Fibronectin levels in pregnancy and puerperium. Clin Exp Obstet Gynecol. 16:1989;59-60.
Ballegeer V., Spitz B., Kieckens L., Moreau H., Van Assche A., Collen D. Predictive value of increased plasma levels of fibronectin in gestational hypertension. Am J Obstet Gynecol. 161:1989;432-436.
Ballegeer V.C., Spitz B., De Baene L.A., Van Assche A.F., Hidajat M., Criel A.M. Platelet activation and vascular damage in gestational hypertension. Am J Obstet Gynecol. 166:1992;629-633.
Halligan A., Bonnar J., Sheppard B., Darling M., Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol. 101:1994;488-492.
Conde-Agudelo A., Lede R., Belizan J. Evaluation of methods used in the prediction of hypertensive disorders of pregnancy. Obstet Gynecol Surv. 49:1994;210-221.
Magann E.F., Martin J.N. Jr. The laboratory evaluation of hypertensive gravidas. Obstet Gynecol Surv. 50:1995;138-145.
Davey D.A., MacGillivray I. The classification of the hypertensive disorders of pregnancy. Clin Exp Hypertens. B5:1986;97-133.
Rennard S.I., Berg R., Martin G.R., Foidart J.M., Gehron-Robey P. Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem. 104:1980;205-214.
Lockwood C.J., Peters J.H. Increased plasma levels of ED1 + cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol. 162:1990;358-362.
Stubbs TM, Lazarchick J, Miller MC, Lee FC, Janszen D. Plasma fibronectin: not a useful early marker for preeclampsia. Am J Obstet Gynecol 1991;164:277 (abstract).
Cadroy Y., Grandjean H., Pichon J.et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol. 100:1993;416-420.
Bewley S., Cooper D., Campbell S. Doppler investigation of uteroplacental blood flow resistance in the second trimester: a screening study for pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol. 98:1991;871-879.
North R.A., Ferrier C., Long D., Townend K., Kincaid-Smith P. Uterine artery Doppler flow velocity waveforms in the second trimester for the prediction of preeclampsia and fetal growth retardation. Obstet Gynecol. 83:1994;378-386.